comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 12:08:10 - browse：4

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Parkland mass shooting to be reenacted for lawsuit

WSS

The Affordable Care Act has saved billions in health care costs

Prosecutors seek bail revocation for FTX founder Sam Bankman

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

California Joshua trees severely burned in massive wildfire

How generative AI ratchets up security threats for health systems

Merck, Johnson & Johnson CEOs will testify on high drug prices

focus

comprehensive

explore

Anesthesiologist group: stop taking Ozempic before surgery

Investment in vaccine development is lagging, report finds

After affirmative action ruling, medical educators look to 'holistic review'

The Affordable Care Act has saved billions in health care costs

Malaria cases in Florida and Texas: Here’s what you need to know

'Cuddling' is just what the doctor ordered for a 200

Malaria cases in Florida and Texas: Here’s what you need to know

Russian court extends detention of American musician

23andMe had bad news about my health. I wish a person had delivered it

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

hotspot

Health Care Service Corp to buy Cigna Medicare Advantage plans

Medical schools are missing the mark on artificial intelligence

Venture capital firm's plans to take over Akron hospital face hurdles

Biogen walks away from Aduhelm, years after polarizing approval

Why Medicare shouldn’t cover every FDA

Why you shouldn’t ask, “What country has the best health care?”

entertainment

focus

focus

Wikipedia